Article info
Clinical and epidemiological research
Incidences of overall and site specific cancers in TNFα inhibitor treated patients with rheumatoid arthritis and other arthritides – a follow-up study from the DANBIO Registry
- Correspondence to Dr Lene Dreyer, Department of Rheumatology, Gentofte University Hospital, Niels Andersens Vej 65, 2900 Hellerup, Denmark; lene.dreyer{at}dadlnet.dk
Citation
Incidences of overall and site specific cancers in TNFα inhibitor treated patients with rheumatoid arthritis and other arthritides – a follow-up study from the DANBIO Registry
Publication history
- Received May 7, 2012
- Accepted August 2, 2012
- First published September 3, 2012.
Online issue publication
December 12, 2012
Article Versions
- Previous version (3 September 2012).
- Previous version (17 September 2012).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions